Literature DB >> 22829250

Near fatal case of amlodipine poisoning in an infant.

Somashekhar M Nimbalkar1, Dipen Vasudev Patel.   

Abstract

An 11-mo-old infant received 12.5 times the maximum therapeutic dose of amlodipine as a result of a medication error in lieu of amoxicillin. He presented with vomiting, lethargy, breathlessness, muffled heart sounds and progressed to hypotensive shock within three hours of admission. He received mechanical ventilation, fluid therapy with normal saline and inotropes. But his parameters improved rapidly only after initiating him on insulin and dextrose infusion therapy (for 15 h) along with glucagon and calcium gluconate infusion (for 72 h). Calcium channel blockers (CCB) cause impaired insulin secretion causing hyperglycemia. High levels of blood sugar are of prognostic value rather than hemodynamic variables in CCB poisoning. A continuous infusion of 0.5 to 1 unit per kg body weight per hour of insulin along with supportive therapy including peritoneal dialysis (for deranged renal function) was used with success in managing amlodipine poisoning.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829250     DOI: 10.1007/s12098-012-0861-2

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

Review 1.  Amlodipine fatality in an infant with postmortem blood levels.

Authors:  Henry A Spiller; Beth A Milliner; George M Bosse
Journal:  J Med Toxicol       Date:  2012-06

2.  Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines.

Authors:  J A Kline; R M Raymond; E D Leonova; T C Williams; J A Watts
Journal:  Cardiovasc Res       Date:  1997-05       Impact factor: 10.787

3.  Amlodipine overdose causes prolonged calcium channel blocker toxicity.

Authors:  B D Adams; W T Browne
Journal:  Am J Emerg Med       Date:  1998-09       Impact factor: 2.469

4.  2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report.

Authors:  Alvin C Bronstein; Daniel A Spyker; Louis R Cantilena; Jody L Green; Barry H Rumack; Sandra L Giffin
Journal:  Clin Toxicol (Phila)       Date:  2009-12       Impact factor: 4.467

Review 5.  Cardiovascular challenges in toxicology.

Authors:  Christopher P Holstege; Stephen Dobmeier
Journal:  Emerg Med Clin North Am       Date:  2005-11       Impact factor: 2.264

6.  Fatal nifedipine ingestions in children.

Authors:  D C Lee; T Greene; T Dougherty; P Pearigen
Journal:  J Emerg Med       Date:  2000-11       Impact factor: 1.484

Review 7.  Management of calcium channel antagonist overdose.

Authors:  Steven D Salhanick; Michael W Shannon
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Amlodipine toxicity in children less than 6 years of age: a dose-response analysis using national poison data system data.

Authors:  Blaine E Benson; Daniel A Spyker; William G Troutman; William A Watson; Ludmila N Bakhireva
Journal:  J Emerg Med       Date:  2009-06-17       Impact factor: 1.484

9.  Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil.

Authors:  Michael Levine; Edward W Boyer; Charles N Pozner; Ann-Jeannette Geib; Todd Thomsen; Nathan Mick; Stephen H Thomas
Journal:  Crit Care Med       Date:  2007-09       Impact factor: 7.598

Review 10.  Bench-to-bedside review: hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers.

Authors:  Philippe E R Lheureux; Soheil Zahir; Mireille Gris; Anne-Sophie Derrey; Andrea Penaloza
Journal:  Crit Care       Date:  2006-05-22       Impact factor: 9.097

  10 in total
  2 in total

Review 1.  Management of Calcium Channel Blocker Toxicity in the Pediatric Patient.

Authors:  Jenna W Bartlett; Pamela L Walker
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Sep-Oct

Review 2.  Treatment for calcium channel blocker poisoning: a systematic review.

Authors:  M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais
Journal:  Clin Toxicol (Phila)       Date:  2014-10-06       Impact factor: 4.467

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.